A lawsuit from one of the biggest pharmaceutical companies in the world
For example, in this case, a Maryland man was criminally prosecuted for selling bodybuilding peptides with research/laboratory use only claims, which the government explained were used as a ruse to avoid FDA scrutiny. This case saw the same result, with the government explaining that the defendants employed the bogus research chemicals disclaimer to conceal that they and others were distributing misbranded drugs and unapproved new drugs for use by their customers. Ultimately, GLP-1s are a relatively new phenomenon presenting many novel legal issues for FDA and stakeholders
Wang, W.-A., Groenendyk, J
Nature 617 , 581591 (2023)
Future research should use longer follow-up periods to validate the model estimates
But Christoph Buettner, MD, PhD, the chief of the division of endocrinology at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, says thats not a huge increase from tirzepatide